Status:
COMPLETED
Magnetically Navigated vs. Manually Guided Radiofrequency in Atrioventricular-node-reentry-tachycardia
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Collaborating Sponsors:
University of Bergen
Conditions:
Atrioventricular Nodal Reentry Tachycardia
Radiofrequency Ablation
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The MAGMA-AVNRT study compares two different methods of handling the ablation catheters for av-node-reentry-tachycardia with regard to x-ray dose, safety and success: manually guided vs magnetically n...
Detailed Description
AV-node reentry tachycardia can be treated by radiofrequency ablation or modulation of the slow pathway of the av node. The success rate is 90 to 95%. There are different options to navigate the abla...
Eligibility Criteria
Inclusion
- 18 to 70 years old
- suspected AV-node-reentry-tachycardia
- written informed consent
Exclusion
- pregnancy
- contraindication against electrophysiological study or ablation
- congenital heart disease or other anatomical abnormalities
- previous surgical procedure involving atrium except aorto-coronary bypass grafts
- psychiatric disease that makes a completion of study improbable
- severe comorbidities with a life expectancy less than 6 months
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00875914
Start Date
April 1 2009
End Date
October 1 2012
Last Update
June 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bergen
Bergen, Norway, 5021